AD and IL4 IL13 biologic therapies

CE / CME

Atopic Dermatitis and Biologic Therapies: Identifying Candidates for IL-4/IL-13– and IL-13–Targeted Treatment

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Released: April 30, 2025

Expiration: April 29, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

When assessing atopic dermatitis (AD) severity in patients with moderate to severe AD, what surrogate measure can be used as an adjunctive assessment?